败血症或感染性休克患者抗生素起始的适当时机:一项系统回顾和荟萃分析。

IF 2.4 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Korean Journal of Internal Medicine Pub Date : 2025-09-01 Epub Date: 2025-08-26 DOI:10.3904/kjim.2025.037
Nam Su Ku, Yongseop Lee, Dae Won Park
{"title":"败血症或感染性休克患者抗生素起始的适当时机:一项系统回顾和荟萃分析。","authors":"Nam Su Ku, Yongseop Lee, Dae Won Park","doi":"10.3904/kjim.2025.037","DOIUrl":null,"url":null,"abstract":"<p><p>Evidence supporting antibiotic administration within 3 hours in sepsis without shock is limited. Therefore, we conducted a systematic review and meta-analysis to determine whether the timing of antibiotic initiation influences mortality in patients with sepsis or septic shock. We comprehensively searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, and the Korean Medical Database from inception to November, 2022, using the keywords \"sepsis,\" \"septic shock,\" \"anti-bacterial agents,\" \"time to treatment,\" and \"time factors.\" Two reviewers independently performed eligibility screening and full-text review. Thirteen studies including 79,246 patients were analyzed: five prospective, seven retrospective, and one retrospective case-control study. In overall sepsis cases, mortality did not differ significantly between patients who received antibiotics within 1 hour and those in the delayed group but was significantly lower in those who received antibiotics within 3 hours than in those in the delayed group. In patients with septic shock, mortality was significantly lower in groups that received antibiotics within both 1 and 3 hours than in the delayed group. In septic shock, administration of antibiotics within 1 hour of diagnosis reduces mortality. In patients with sepsis, antibiotic administration within 3 hours, but not necessarily within 1 hour, was associated with reduced mortality.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"725-733"},"PeriodicalIF":2.4000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12425674/pdf/","citationCount":"0","resultStr":"{\"title\":\"Appropriate timing of antibiotic initiation in patients with sepsis or septic shock: a systematic review and meta-analysis.\",\"authors\":\"Nam Su Ku, Yongseop Lee, Dae Won Park\",\"doi\":\"10.3904/kjim.2025.037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Evidence supporting antibiotic administration within 3 hours in sepsis without shock is limited. Therefore, we conducted a systematic review and meta-analysis to determine whether the timing of antibiotic initiation influences mortality in patients with sepsis or septic shock. We comprehensively searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, and the Korean Medical Database from inception to November, 2022, using the keywords \\\"sepsis,\\\" \\\"septic shock,\\\" \\\"anti-bacterial agents,\\\" \\\"time to treatment,\\\" and \\\"time factors.\\\" Two reviewers independently performed eligibility screening and full-text review. Thirteen studies including 79,246 patients were analyzed: five prospective, seven retrospective, and one retrospective case-control study. In overall sepsis cases, mortality did not differ significantly between patients who received antibiotics within 1 hour and those in the delayed group but was significantly lower in those who received antibiotics within 3 hours than in those in the delayed group. In patients with septic shock, mortality was significantly lower in groups that received antibiotics within both 1 and 3 hours than in the delayed group. In septic shock, administration of antibiotics within 1 hour of diagnosis reduces mortality. In patients with sepsis, antibiotic administration within 3 hours, but not necessarily within 1 hour, was associated with reduced mortality.</p>\",\"PeriodicalId\":48785,\"journal\":{\"name\":\"Korean Journal of Internal Medicine\",\"volume\":\" \",\"pages\":\"725-733\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12425674/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Korean Journal of Internal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3904/kjim.2025.037\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3904/kjim.2025.037","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

没有休克的败血症患者在3小时内给予抗生素的证据是有限的。因此,我们进行了系统回顾和荟萃分析,以确定抗生素开始使用的时间是否会影响脓毒症或感染性休克患者的死亡率。我们综合检索了PubMed, EMBASE, Cochrane中央对照试验注册库和韩国医学数据库,从成立到2022年11月,使用关键词“败血症”,“感染性休克”,“抗菌药物”,“治疗时间”和“时间因素”。两名审稿人独立进行资格筛选和全文审查。13项研究包括79246例患者,其中5项为前瞻性研究,7项为回顾性研究,1项为回顾性病例对照研究。在总体脓毒症病例中,1小时内接受抗生素治疗的患者死亡率与延迟治疗组之间无显著差异,但3小时内接受抗生素治疗的患者死亡率明显低于延迟治疗组。在脓毒性休克患者中,在1和3小时内接受抗生素治疗的患者死亡率明显低于延迟治疗组。在感染性休克中,诊断后1小时内给予抗生素可降低死亡率。在脓毒症患者中,在3小时内(但不一定在1小时内)给予抗生素与死亡率降低有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Appropriate timing of antibiotic initiation in patients with sepsis or septic shock: a systematic review and meta-analysis.

Appropriate timing of antibiotic initiation in patients with sepsis or septic shock: a systematic review and meta-analysis.

Appropriate timing of antibiotic initiation in patients with sepsis or septic shock: a systematic review and meta-analysis.

Appropriate timing of antibiotic initiation in patients with sepsis or septic shock: a systematic review and meta-analysis.

Evidence supporting antibiotic administration within 3 hours in sepsis without shock is limited. Therefore, we conducted a systematic review and meta-analysis to determine whether the timing of antibiotic initiation influences mortality in patients with sepsis or septic shock. We comprehensively searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, and the Korean Medical Database from inception to November, 2022, using the keywords "sepsis," "septic shock," "anti-bacterial agents," "time to treatment," and "time factors." Two reviewers independently performed eligibility screening and full-text review. Thirteen studies including 79,246 patients were analyzed: five prospective, seven retrospective, and one retrospective case-control study. In overall sepsis cases, mortality did not differ significantly between patients who received antibiotics within 1 hour and those in the delayed group but was significantly lower in those who received antibiotics within 3 hours than in those in the delayed group. In patients with septic shock, mortality was significantly lower in groups that received antibiotics within both 1 and 3 hours than in the delayed group. In septic shock, administration of antibiotics within 1 hour of diagnosis reduces mortality. In patients with sepsis, antibiotic administration within 3 hours, but not necessarily within 1 hour, was associated with reduced mortality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Korean Journal of Internal Medicine
Korean Journal of Internal Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.10
自引率
4.20%
发文量
129
审稿时长
20 weeks
期刊介绍: The Korean Journal of Internal Medicine is an international medical journal published in English by the Korean Association of Internal Medicine. The Journal publishes peer-reviewed original articles, reviews, and editorials on all aspects of medicine, including clinical investigations and basic research. Both human and experimental animal studies are welcome, as are new findings on the epidemiology, pathogenesis, diagnosis, and treatment of diseases. Case reports will be published only in exceptional circumstances, when they illustrate a rare occurrence of clinical importance. Letters to the editor are encouraged for specific comments on published articles and general viewpoints.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信